<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06350000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P14210</UniProt_ID>
  <Seq_Length>728</Seq_Length>
  <Molecule_Weight>83134</Molecule_Weight>
  <KEGG_ID>hsa:3082</KEGG_ID>
  <Orthology_ID>K05460</Orthology_ID>
  <EBI_ID>EBI-1039104</EBI_ID>
  <Function_Summary>HGF is a potent mitogen for mature parenchymal hepatocyte cells, seems to be an hepatotrophic factor, and acts as growth factor for a broad spectrum of tissues and cell types. It has no detectable protease activity.</Function_Summary>
  <Pfam_ID>PF00051:Kringle@@PF00024:PAN_1@@PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>12</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>40</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Hepatocyte growth factor beta chain</Alias>
      <Alias>Hepatopoietin-A</Alias>
      <Alias>Scatter factor</Alias>
      <Alias>SF</Alias>
      <Alias>Hepatocyte growth factor alpha chain</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.</Detail>
      <Keyword>Growth factor activity</Keyword>
      <Ontology_ID>GO:0008083</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Protein which is related to serine proteases but seems to have no proteolytic activity.</Detail>
      <Keyword>Serine protease homolog</Keyword>
      <Ontology_ID>KW-0721</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>304</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>330</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.</Detail>
      <Keyword>Positive regulation of peptidyl-tyrosine phosphorylation</Keyword>
      <Ontology_ID>GO:0050731</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Hepatocyte growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048012</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).</Detail>
      <Keyword>Cell chemotaxis</Keyword>
      <Ontology_ID>GO:0060326</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.</Detail>
      <Keyword>Platelet degranulation</Keyword>
      <Ontology_ID>GO:0002576</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.</Detail>
      <Keyword>Mitosis</Keyword>
      <Ontology_ID>GO:0007067</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium.</Detail>
      <Keyword>Regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling</Keyword>
      <Ontology_ID>GO:0060665</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.</Detail>
      <Keyword>Epithelial to mesenchymal transition</Keyword>
      <Ontology_ID>GO:0001837</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>32</Position>
      <PTM_Type>Pyrrolidone carboxylic acid</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MWVTKLLPALLLQHVLLHLLLLPIAIPYAEGQRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCADNTMNDTDVPLETTECIQGQGEGYRGTVNTIWNGIPCQRWDSQYPHEHDMTPENFKCKDLRENYCRNPDGSESPWCFTTDPNIRVGYCSQIPNCDMSHGQDCYRGNGKNYMGNLSQTRSGLTCSMWDKNMEDLHRHIFWEPDASKLNENYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEGDTTPTIVNLDHPVISCAKTKQLRVVNGIPTRTNIGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYTGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILTYKVPQS</Protein_Seq>
    <DNA_Seq>GGGAGTTCAGACCTAGATCTTTCCAGTTAATCACACAACAAACTTAGCTCATCGCAATAAAAAGCAGCTCAGAGCCGACTGGCTCTTTTAGGCACTGACTCCGAACAGGATTCTTTCACCCAGGCATCTCCTCCAGAGGGATCCGCCAGCCCGTCCAGCAGCACCATGTGGGTGACCAAACTCCTGCCAGCCCTGCTGCTGCAGCATGTCCTCCTGCATCTCCTCCTGCTCCCCATCGCCATCCCCTATGCAGAGGGACAAAGGAAAAGAAGAAATACAATTCATGAATTCAAAAAATCAGCAAAGACTACCCTAATCAAAATAGATCCAGCACTGAAGATAAAAACCAAAAAAGTGAATACTGCAGACCAATGTGCTAATAGATGTACTAGGAATAAAGGACTTCCATTCACTTGCAAGGCTTTTGTTTTTGATAAAGCAAGAAAACAATGCCTCTGGTTCCCCTTCAATAGCATGTCAAGTGGAGTGAAAAAAGAATTTGGCCATGAATTTGACCTCTATGAAAACAAAGACTACATTAGAAACTGCATCATTGGTAAAGGACGCAGCTACAAGGGAACAGTATCTATCACTAAGAGTGGCATCAAATGTCAGCCCTGGAGTTCCATGATACCACACGAACACAGCTTTTTGCCTTCGAGCTATCGGGGTAAAGACCTACAGGAAAACTACTGTCGAAATCCTCGAGGGGAAGAAGGGGGACCCTGGTGTTTCACAAGCAATCCAGAGGTACGCTACGAAGTCTGTGACATTCCTCAGTGTTCAGAAGTTGAATGCATGACCTGCAATGGGGAGAGTTATCGAGGTCTCATGGATCATACAGAATCAGGCAAGATTTGTCAGCGCTGGGATCATCAGACACCACACCGGCACAAATTCTTGCCTGAAAGATATCCCGACAAGGGCTTTGATGATAATTATTGCCGCAATCCCGATGGCCAGCCGAGGCCATGGTGCTATACTCTTGACCCTCACACCCGCTGGGAGTACTGTGCAATTAAAACATGCGCTGACAATACTATGAATGACACTGATGTTCCTTTGGAAACAACTGAATGCATCCAAGGTCAAGGAGAAGGCTACAGGGGCACTGTCAATACCATTTGGAATGGAATTCCATGTCAGCGTTGGGATTCTCAGTATCCTCACGAGCATGACATGACTCCTGAAAATTTCAAGTGCAAGGACCTACGAGAAAATTACTGCCGAAATCCAGATGGGTCTGAATCACCCTGGTGTTTTACCACTGATCCAAACATCCGAGTTGGCTACTGCTCCCAAATTCCAAACTGTGATATGTCACATGGACAAGATTGTTATCGTGGGAATGGCAAAAATTATATGGGCAACTTATCCCAAACAAGATCTGGACTAACATGTTCAATGTGGGACAAGAACATGGAAGACTTACATCGTCATATCTTCTGGGAACCAGATGCAAGTAAGCTGAATGAGAATTACTGCCGAAATCCAGATGATGATGCTCATGGACCCTGGTGCTACACGGGAAATCCACTCATTCCTTGGGATTATTGCCCTATTTCTCGTTGTGAAGGTGATACCACACCTACAATAGTCAATTTAGACCATCCCGTAATATCTTGTGCCAAAACGAAACAATTGCGAGTTGTAAATGGGATTCCAACACGAACAAACATAGGATGGATGGTTAGTTTGAGATACAGAAATAAACATATCTGCGGAGGATCATTGATAAAGGAGAGTTGGGTTCTTACTGCACGACAGTGTTTCCCTTCTCGAGACTTGAAAGATTATGAAGCTTGGCTTGGAATTCATGATGTCCACGGAAGAGGAGATGAGAAATGCAAACAGGTTCTCAATGTTTCCCAGCTGGTATATGGCCCTGAAGGATCAGATCTGGTTTTAATGAAGCTTGCCAGGCCTGCTGTCCTGGATGATTTTGTTAGTACGATTGATTTACCTAATTATGGATGCACAATTCCTGAAAAGACCAGTTGCAGTGTTTATGGCTGGGGCTACACTGGATTGATCAACTATGATGGCCTATTACGAGTGGCACATCTCTATATAATGGGAAATGAGAAATGCAGCCAGCATCATCGAGGGAAGGTGACTCTGAATGAGTCTGAAATATGTGCTGGGGCTGAAAAGATTGGATCAGGACCATGTGAGGGGGATTATGGTGGCCCACTTGTTTGTGAGCAACATAAAATGAGAATGGTTCTTGGTGTCATTGTTCCTGGTCGTGGATGTGCCATTCCAAATCGTCCTGGTATTTTTGTCCGAGTAGCATATTATGCAAAATGGATACACAAAATTATTTTAACATATAAGGTACCACAGTCATAGCTGAAGTAAGTGTGTCTGAAGCACCCACCAATACAACTGTCTTTTACATGAAGATTTCAGAGAATGTGGAATTTAAAATGTCACTTACAACAATCCTAAGACAACTACTGGAGAGTCATGTTTGTTGAAATTCTCATTAATGTTTATGGGTGTTTTCTGTTGTTTTGTTTGTCAGTGTTATTTTGTCAATGTTGAAGTGAATTAAGGTACATGCAAGTGTAATAACATATCTCCTGAAGATACTTGAATGGATTAAAAAAACACACAGGTATATTTGCTGGATGATAAAGATTTCATGGGAAAAAAAATCAATTAATCTGTCTAAGCTGCTTTCTGATGTTGGTTTCTTAATAATGAGTAAACCACAAATTAAATGTTATTTTAACCTCACCAAAACAATTTATACCTTGTGTCCCTAAATTGTAGCCCTATATTAAATTATATTACATTTCAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Platelet alpha granule lumen</CellLocal>
      <Ontology_ID>GO:0031093</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HGF</Gene_Name>
    <Gene_Alias>HPTA</Gene_Alias>
    <Gene_ID>3082</Gene_ID>
    <Genbank_ACCN>NM_000601</Genbank_ACCN>
    <Protein_ACCN>NP_000592</Protein_ACCN>
    <HGNC_ID>4893</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3082</Gene_URL>
    <UCSC_ID>uc003uhp.3</UCSC_ID>
    <EMBL_ID>ENSG00000019991</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P16056</Uniprot_ID>
      <Gene_Name>Met</Gene_Name>
      <EBI_ID>EBI-1798780</EBI_ID>
      <PPI_EBI_URL>EBI-1039104,EBI-1798780</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P08581</Uniprot_ID>
      <Gene_Name>MET</Gene_Name>
      <EBI_ID>EBI-1039152</EBI_ID>
      <PPI_EBI_URL>EBI-1039104,EBI-1039152</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Nodular Goiter</Disease_Name>
      <Disease_Detail>Nodular Goiter</Disease_Detail>
      <Disease_DB>NDL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nodular_goiter?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Salivary Gland Cancer</Disease_Name>
      <Disease_Detail>Salivary Gland Cancer</Disease_Detail>
      <Disease_DB>SLV002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/salivary_gland_cancer?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Myocardial Ischemia</Disease_Name>
      <Disease_Detail>Chronic Myocardial Ischemia</Disease_Detail>
      <Disease_DB>CHR413</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_myocardial_ischemia?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Angle-Closure Glaucoma</Disease_Name>
      <Disease_Detail>Primary Angle-Closure Glaucoma</Disease_Detail>
      <Disease_DB>PRM024</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_angle_closure_glaucoma?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cholangiocarcinoma</Disease_Name>
      <Disease_Detail>Cholangiocarcinoma</Disease_Detail>
      <Disease_DB>CHL065</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cholangiocarcinoma?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eosinophilic Meningitis</Disease_Name>
      <Disease_Detail>Eosinophilic Meningitis</Disease_Detail>
      <Disease_DB>ESN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eosinophilic_meningitis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome 4</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome_4?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arteriosclerosis Obliterans</Disease_Name>
      <Disease_Detail>Arteriosclerosis Obliterans</Disease_Detail>
      <Disease_DB>ART008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriosclerosis_obliterans?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Diabetes Mellitus</Disease_Name>
      <Disease_Detail>Diabetes Mellitus</Disease_Detail>
      <Disease_DB>DBT009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/diabetes_mellitus?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Deafness, Autosomal Recessive 39</Disease_Name>
      <Disease_Detail>Deafness</Disease_Detail>
      <Disease_DB>DFN120</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deafness_autosomal_recessive_39?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Fibrosis</Disease_Name>
      <Disease_Detail>Renal Fibrosis</Disease_Detail>
      <Disease_DB>RNL077</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_fibrosis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Biliary Atresia</Disease_Name>
      <Disease_Detail>Biliary Atresia</Disease_Detail>
      <Disease_DB>BLR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/biliary_atresia?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Kaposi's Sarcoma</Disease_Name>
      <Disease_Detail>Kaposi's Sarcoma</Disease_Detail>
      <Disease_DB>KPS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/kaposis_sarcoma?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Cirrhosis</Disease_Name>
      <Disease_Detail>Liver Cirrhosis</Disease_Detail>
      <Disease_DB>LVR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_cirrhosis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Crohn Disease-Associated Growth Failure</Disease_Name>
      <Disease_Detail>Crohn Disease-Associated Growth Failure</Disease_Detail>
      <Disease_DB>CRH004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/crohn_disease_associated_growth_failure?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spinocerebellar Ataxia Type 7</Disease_Name>
      <Disease_Detail>Spinocerebellar Ataxia</Disease_Detail>
      <Disease_DB>SPN069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spinocerebellar_ataxia_type_7?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Salivary Gland Tumor</Disease_Name>
      <Disease_Detail>Salivary Gland Tumor</Disease_Detail>
      <Disease_DB>SLV021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/salivary_gland_tumor?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intracranial Hemorrhage in Brain Cerebrovascular Malformations</Disease_Name>
      <Disease_Detail>Intracranial Hemorrhage in Brain Cerebrovascular Malformations</Disease_Detail>
      <Disease_DB>INT145</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intracranial_hemorrhage_in_brain_cerebrovascular_malformations?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Limb Ischemia</Disease_Name>
      <Disease_Detail>Limb Ischemia</Disease_Detail>
      <Disease_DB>LMB062</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/limb_ischemia?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastroenteritis</Disease_Name>
      <Disease_Detail>Gastroenteritis</Disease_Detail>
      <Disease_DB>GST045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastroenteritis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcoholic Hepatitis</Disease_Name>
      <Disease_Detail>Alcoholic Hepatitis</Disease_Detail>
      <Disease_DB>ALC006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcoholic_hepatitis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dfnb39 Nonsyndromic Hearing Loss and Deafness</Disease_Name>
      <Disease_Detail>Nonsyndromic Hearing Loss and Deafness</Disease_Detail>
      <Disease_DB>DFN083</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dfnb39_nonsyndromic_hearing_loss_and_deafness?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Deafness, Digenic, Gjb2/gjb3</Disease_Name>
      <Disease_Detail>Deafness</Disease_Detail>
      <Disease_DB>DFN101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deafness_digenic_gjb2_gjb3?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fibromatosis, Gingival</Disease_Name>
      <Disease_Detail>Fibromatosis</Disease_Detail>
      <Disease_DB>FBR045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fibromatosis_gingival?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Wrinkles</Disease_Name>
      <Disease_Detail>Wrinkles</Disease_Detail>
      <Disease_DB>WRN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/wrinkles?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Rheumatoid Arthritis</Disease_Name>
      <Disease_Detail>Juvenile Rheumatoid Arthritis</Disease_Detail>
      <Disease_DB>JVN010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_rheumatoid_arthritis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Papillary Carcinoma</Disease_Name>
      <Disease_Detail>Papillary Carcinoma</Disease_Detail>
      <Disease_DB>PPL002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/papillary_carcinoma?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arteriosclerosis</Disease_Name>
      <Disease_Detail>Arteriosclerosis</Disease_Detail>
      <Disease_DB>ART021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriosclerosis?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastric Ulcer</Disease_Name>
      <Disease_Detail>Gastric Ulcer</Disease_Detail>
      <Disease_DB>GST023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastric_ulcer?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Medulloblastoma</Disease_Name>
      <Disease_Detail>Medulloblastoma</Disease_Detail>
      <Disease_DB>MDL005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/medulloblastoma?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Proliferative Diabetic Retinopathy</Disease_Name>
      <Disease_Detail>Proliferative Diabetic Retinopathy</Disease_Detail>
      <Disease_DB>PRL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/proliferative_diabetic_retinopathy?search=HGF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometriosis</Disease_Name>
      <Disease_Detail>Endometriosis</Disease_Detail>
      <Disease_DB>END044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometriosis?search=HGF#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR</PDB_Title>
      <PDB_ID>1BHT</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BHT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.</PubMed_Title>
      <Author>Ultsch, M., et al.</Author>
      <Journal>Structure(1998)6:1383-1393</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9817840?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION</PDB_Title>
      <PDB_ID>1NK1</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NK1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.</PubMed_Title>
      <Author>Chirgadze, D.Y., et al.</Author>
      <Journal>Nat.Struct.Biol.(1999)6:72-79</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9886295?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Crystal structure of the N-terminal fragment (28-126) of the human hepatocyte growth factor/scatter factor, orthorhombic crystal form</PDB_Title>
      <PDB_ID>3HMS</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HMS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for agonism and antagonism of hepatocyte growth factor.</PubMed_Title>
      <Author>Tolbert, W.D., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:13264-13269</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20624990?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING</PDB_Title>
      <PDB_ID>1GP9</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GP9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A New Crystal Form of the Nk1 Splice Variant of Hgf/Sf Demonstrates Extensive Hinge Movement and Suggests that the Nk1 Dimer Originates by Domain Swapping</PubMed_Title>
      <Author>Watanabe, K., et al.</Author>
      <Journal>J.Mol.Biol.(2002)319:283</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12051906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR</PDB_Title>
      <PDB_ID>1GMO</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GMO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor</PubMed_Title>
      <Author>Lietha, D., et al.</Author>
      <Journal>Embo J.(2001)20:5543-5555</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11597998?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR</PDB_Title>
      <PDB_ID>1GMN</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GMN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor</PubMed_Title>
      <Author>Lietha, D., et al.</Author>
      <Journal>Embo J.(2001)20:5543-5555</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11597998?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A Mechanistic Basis for Converting a Receptor Tyrosine Kinase Agonist to an Antagonist</PDB_Title>
      <PDB_ID>2QJ2</PDB_ID>
      <Resolution>1.81</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QJ2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist</PubMed_Title>
      <Author>Tolbert, W.D., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2007)104:14592-14597</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17804794?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the NK2 fragment (28-289) of human hepatocyte growth factor/scatter factor</PDB_Title>
      <PDB_ID>3HN4</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HN4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for agonism and antagonism of hepatocyte growth factor.</PubMed_Title>
      <Author>Tolbert, W.D., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:13264-13269</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20624990?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>2HGF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HGF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site.</PubMed_Title>
      <Author>Zhou, H., et al.</Author>
      <Journal>Structure(1998)6:109-116</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9493272?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Crystal Structure of HGF beta-chain in Complex with the Sema Domain of the Met Receptor.</PDB_Title>
      <PDB_ID>1SHY</PDB_ID>
      <Resolution>3.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SHY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor.</PubMed_Title>
      <Author>Stamos, J., et al.</Author>
      <Journal>Embo J.(2004)23:2325-2335</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15167892?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of 1K1 mutant of Hepatocyte Growth Factor/Scatter Factor fragment NK1 in complex with heparin</PDB_Title>
      <PDB_ID>3MKP</PDB_ID>
      <Resolution>2.81</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MKP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Engineering a fragment of Hepatocyte Growth Factor/Scatter Factor for tissue and organ regeneration</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the N-terminal fragment (28-126) of the human hepatocyte growth factor/scatter factor, trigonal crystal form</PDB_Title>
      <PDB_ID>3HMT</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HMT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for agonism and antagonism of hepatocyte growth factor.</PubMed_Title>
      <Author>Tolbert, W.D., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:13264-13269</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20624990?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Protease-like domain from 2-chain hepatocyte growth factor</PDB_Title>
      <PDB_ID>1SI5</PDB_ID>
      <Resolution>2.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SI5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling</PubMed_Title>
      <Author>Kirchhofer, D., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:39915-39924</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15218027?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05211</Pathway_ID>
      <Pathway_Title>Renal cell carcinoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04510</Pathway_ID>
      <Pathway_Title>Focal adhesion</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04060</Pathway_ID>
      <Pathway_Title>Cytokine-cytokine receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05144</Pathway_ID>
      <Pathway_Title>Malaria</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Small proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.h.ba.b.b.b.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1bht</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD06350001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06350040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352009</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352010</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352011</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06352012</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>